Pages that link to "Q46802647"
Jump to navigation
Jump to search
The following pages link to Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial (Q46802647):
Displaying 37 items.
- Pharmacological management of behavioral symptoms associated with dementia (Q28081955) (← links)
- Chronic divalproex sodium use and brain atrophy in Alzheimer disease (Q30424864) (← links)
- Seizures in Alzheimer disease: clinical and epidemiological data (Q30575767) (← links)
- Use of gabapentin in the treatment of behavioural and psychological symptoms of dementia: a review of the evidence (Q33323206) (← links)
- Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials? (Q33591977) (← links)
- Pharmacology of epigenetics in brain disorders (Q33673025) (← links)
- Alzheimer's therapies (Q33894697) (← links)
- A systematic mapping review of randomized controlled trials (RCTs) in care homes (Q34316513) (← links)
- Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review (Q34452896) (← links)
- Risk of mortality among individual antipsychotics in patients with dementia (Q34634590) (← links)
- Pharmacotherapy of neuropsychiatric symptoms of dementia (Q35229781) (← links)
- Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease (Q35765716) (← links)
- Divalproex sodium for the treatment of behavioural problems associated with dementia in the elderly (Q36655153) (← links)
- Epigenetics-Based Therapeutics for Neurodegenerative Disorders (Q36697733) (← links)
- Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach? (Q36729609) (← links)
- ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia (Q36885358) (← links)
- Drug Therapy for Behavioral and Psychological Symptoms of Dementia (Q36925888) (← links)
- Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review (Q37019262) (← links)
- Detection and management of pre-existing cognitive impairment and associated behavioral symptoms in the Intensive Care Unit (Q37029708) (← links)
- Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium (Q37052151) (← links)
- Alternatives to atypical antipsychotics for the management of dementia-related agitation. (Q37151230) (← links)
- Management of agitation and aggression associated with Alzheimer disease (Q37504709) (← links)
- Sleep disorders in neurodegenerative diseases other than Parkinson's disease (Q37807704) (← links)
- Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy? (Q38252709) (← links)
- Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease. (Q38955402) (← links)
- Management of Behavioral and Psychological Symptoms of Dementia (Q39209888) (← links)
- Use of atypical antipsychotics in the elderly (Q41507819) (← links)
- Anticonvulsants in the treatment of aggression in the demented elderly: an update (Q42081136) (← links)
- A shift in the paradigm of treatment (Q42419056) (← links)
- Calming the Agitated Demented Patient (Q42430006) (← links)
- Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease (Q48968494) (← links)
- A meta-analysis of mood stabilizers for Alzheimer’s disease (Q51829352) (← links)
- Pharmacological treatments for alleviating agitation in dementia: A systematic review and network meta-analysis. (Q53279360) (← links)
- Valproate preparations for agitation in dementia (Q57184240) (← links)
- Interventions for preventing falls in older people in care facilities and hospitals (Q57688804) (← links)
- Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA (Q92101808) (← links)
- Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases (Q92489515) (← links)